We are live on ! Find out more
M

Mirova Portfolio holdings

AUM $2.46B
1-Year Est. Return 11.42%
This Fund
S&P 500
This Quarter Est. Return
+10.13%
1 Year Est. Return
+11.42%
3 Year Est. Return
+32%
5 Year Est. Return
+23.08%
10 Year Est. Return
AUM
$709M
AUM Growth
+$153M
Cap. Flow
+$113M
Cap. Flow %
15.93%
Top 10 Hldgs %
44.37%
Holding
141
New
7
Increased
61
Reduced
36
Closed
22

Top Buys

Rank Stock Value
1
XYL icon
Xylem
XYL
+$7.03M
2
TRMB icon
Trimble
TRMB
+$6.54M
3
CDNS icon
Cadence Design Systems
CDNS
+$5.73M
4
SFM icon
Sprouts Farmers Market
SFM
+$5.64M
5
CL icon
Colgate-Palmolive
CL
+$5.36M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$5.51M
2
EXPO icon
Exponent
EXPO
+$2.07M
3
CSCO icon
Cisco
CSCO
+$2.03M
4
RUN icon
Sunrun
RUN
+$1.84M
5
BFAM icon
Bright Horizons
BFAM
+$1.52M

Sector Composition

Rank Sector Weight
1 Technology 35.01%
2 Healthcare 17.43%
3 Industrials 16.91%
4 Materials 8.62%
5 Consumer Discretionary 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
1
Thermo Fisher Scientific
TMO
$214B
$56.1M 7.91%
138,272
-13,179
-9% -$5.51M
ECL icon
2
Ecolab
ECL
$79.7B
$44.1M 6.22%
163,663
+4,587
+3% +$1.17M
NVDA icon
3
NVIDIA
NVDA
$4.77T
$41.8M 5.9%
264,875
+27,784
+12% +$3.5M
MSFT icon
4
Microsoft
MSFT
$2.96T
$39M 5.5%
78,330
+10,509
+15% +$4.56M
ACN icon
5
Accenture
ACN
$102B
$37.6M 5.31%
125,912
+6,234
+5% +$1.9M
LLY icon
6
Eli Lilly
LLY
$1.09T
$22.5M 3.17%
28,850
+2,125
+8% +$1.65M
WM icon
7
Waste Management
WM
$97.3B
$19.1M 2.7%
83,688
+18,616
+29% +$4.32M
XYL icon
8
Xylem
XYL
$29.9B
$18.7M 2.63%
144,268
+58,047
+67% +$7.03M
TRMB icon
9
Trimble
TRMB
$13.5B
$17.8M 2.51%
234,596
+97,348
+71% +$6.54M
V icon
10
Visa
V
$698B
$17.7M 2.5%
49,953
+4,979
+11% +$1.74M
AWK icon
11
American Water Works
AWK
$27.2B
$16.1M 2.27%
115,904
+36,126
+45% +$5.18M
AXP icon
12
American Express
AXP
$226B
$15.8M 2.23%
49,506
+3,721
+8% +$1.05M
BSY icon
13
Bentley Systems
BSY
$10.9B
$14.3M 2.02%
265,763
+90,166
+51% +$4.17M
CL icon
14
Colgate-Palmolive
CL
$75.7B
$11.9M 1.68%
131,019
+58,759
+81% +$5.36M
BMI icon
15
Badger Meter
BMI
$3.87B
$11.9M 1.67%
48,417
+23,274
+93% +$5.27M
SYK icon
16
Stryker
SYK
$133B
$11.4M 1.61%
28,779
+2,643
+10% +$989K
EBAY icon
17
eBay
EBAY
$51.7B
$11M 1.56%
148,333
+58,934
+66% +$4.18M
CDNS icon
18
Cadence Design Systems
CDNS
$95.6B
$10.7M 1.5%
34,591
+19,690
+132% +$5.73M
SFM icon
19
Sprouts Farmers Market
SFM
$7.33B
$9.87M 1.39%
59,975
+34,536
+136% +$5.64M
ZTS icon
20
Zoetis
ZTS
$32.9B
$9.85M 1.39%
63,170
+31,949
+102% +$5.07M
ISRG icon
21
Intuitive Surgical
ISRG
$131B
$9.42M 1.33%
17,327
+3,060
+21% +$1.6M
IEX icon
22
IDEX
IEX
$16.6B
$8.71M 1.23%
49,611
+24,314
+96% +$4.31M
PG icon
23
Procter & Gamble
PG
$355B
$8.61M 1.21%
54,012
+8,936
+20% +$1.46M
LIN icon
24
Linde
LIN
$240B
$8.57M 1.21%
18,269
+4,536
+33% +$2.07M
FSLR icon
25
First Solar
FSLR
$21.4B
$8.03M 1.13%
48,511
+23,228
+92% +$3.43M

Similar funds

Mirova's Q2 2025 Portfolio in Review

As of Q2 2025, Mirova held 141 positions worth $709M, up 28% from $556M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Mirova deployed $113M of net new capital in Q2 2025, opening 7 new positions and adding to 61 existing holdings. Its largest new stake was Hubbell: 5,000 shares worth $2.04M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $5.51M trimmed.

  • Mirova's largest Q2 2025 buy was Hubbell: 5,000 shares worth $2.04M.
  • Mirova added most to Xylem in Q2 2025, an estimated $7.03M increase.
  • Mirova's biggest Q2 2025 reduction was Thermo Fisher Scientific, cutting an estimated $5.51M.
  • Mirova fully exited Omnicom Group in Q2 2025, selling an estimated $659K.
  • Mirova's ten largest holdings make up 44% of its $709M portfolio in Q2 2025.
  • Mirova opened 7 new positions and closed 22 in Q2 2025.
  • Mirova's portfolio value rose 28% quarter-over-quarter to $709M.

Based on Mirova's 13F filing for Q2 2025, filed 13 Aug 2025.